class IIa HDAC inhibitors (Clayton)

N/A

Report date: 2025/03/14 16:24:45
NME

Base Information

Drug Nameclass IIa HDAC inhibitors (Clayton)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistone deacetylase inhibitors
TargetsHistone deacetylase
Therapy Area/IndicationsCommunicable Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesClayton Foundation For Research
China Registration ClassN/A

Develop Information

Active CompaniesClayton Foundation For Research
Inactive CompaniesN/A
Active IndicationsCommunicable Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A